Information Provided By:
Fly News Breaks for September 9, 2016
TMH
Sep 9, 2016 | 08:17 EDT
Stifel analyst Chad Vanacore says that the large decline in TeamHealth's stock this year has left the shares looking undervalued and has created a buying opportunity. Vanacore is upbeat on the company's new CEO, and he continues to expect the company to benefit from current trends in the healthcare sector. He trimmed his price target on the stock to $43 from $48 but keeps a Buy rating.
News For TMH From the Last 2 Days
There are no results for your query TMH
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.